$14.8 Billion is the total value of VIKING GLOBAL INVESTORS LP's 53 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WFC | New | WELLS FARGO CO NEW | $681,388,000 | – | 12,297,209 | +100.0% | 4.59% | – |
| APC | New | ANADARKO PETE CORP | $179,772,000 | – | 3,964,984 | +100.0% | 1.21% | – |
| AFL | New | AFLAC INC | $165,754,000 | – | 2,133,804 | +100.0% | 1.12% | – |
| BABA | New | ALIBABA GROUP HLDG LTDsponsored ads | $155,119,000 | – | 1,100,913 | +100.0% | 1.04% | – |
| TDG | New | TRANSDIGM GROUP INC | $143,539,000 | – | 533,860 | +100.0% | 0.97% | – |
| MOH | New | MOLINA HEALTHCARE INC | $102,167,000 | – | 1,476,832 | +100.0% | 0.69% | – |
| RJF | New | RAYMOND JAMES FINANCIAL INC | $76,716,000 | – | 956,318 | +100.0% | 0.52% | – |
| FLT | New | FLEETCOR TECHNOLOGIES INC | $68,455,000 | – | 474,690 | +100.0% | 0.46% | – |
| NSC | New | NORFOLK SOUTHERN CORP | $57,208,000 | – | 470,075 | +100.0% | 0.38% | – |
| LOW | New | LOWES COS INC | $57,066,000 | – | 736,048 | +100.0% | 0.38% | – |
| MMC | New | MARSH & MCLENNAN COS INC | $54,427,000 | – | 698,142 | +100.0% | 0.37% | – |
| ANTM | New | ANTHEM INC | $53,933,000 | – | 286,680 | +100.0% | 0.36% | – |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $51,059,000 | – | 397,654 | +100.0% | 0.34% | – |
| KITE | New | KITE PHARMA INC | $49,778,000 | – | 480,155 | +100.0% | 0.34% | – |
| EXPE | New | EXPEDIA INC DEL | $47,660,000 | – | 319,974 | +100.0% | 0.32% | – |
| New | NEURODERM LTD | $21,196,000 | – | 708,898 | +100.0% | 0.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VISA INC | 36 | Q3 2023 | 7.0% |
| AMAZON COM INC | 34 | Q3 2023 | 10.6% |
| META PLATFORMS INC | 34 | Q3 2023 | 10.4% |
| MICROSOFT CORP | 30 | Q3 2023 | 9.1% |
| THERMO FISHER SCIENTIFIC INC | 29 | Q3 2023 | 5.4% |
| NETFLIX INC | 26 | Q2 2023 | 6.0% |
| MASTERCARD INCORPORATED | 25 | Q3 2023 | 3.9% |
| ELEVANCE HEALTH INC | 24 | Q2 2023 | 10.2% |
| ALPHABET INC | 22 | Q2 2021 | 9.3% |
| UNITEDHEALTH GROUP INC | 22 | Q3 2023 | 5.3% |
View VIKING GLOBAL INVESTORS LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Celldex Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Coupa Software IncSold out | February 14, 2023 | 0 | 0.0% |
| FIGS, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Guardant Health, Inc. | February 14, 2023 | 4,107,644 | 4.0% |
| Orion Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| PROCEPT BioRobotics CorpSold out | February 14, 2023 | 0 | 0.0% |
| Frazier Lifesciences Acquisition CorpSold out | November 25, 2022 | 0 | 0.0% |
| Cazoo Group Ltd | November 10, 2022 | 60,000,000 | 7.3% |
| AbCellera Biologics Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Athira Pharma, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View VIKING GLOBAL INVESTORS LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-06-18 |
| 4 | 2024-06-18 |
| SC 13G/A | 2024-06-18 |
| 3 | 2024-06-07 |
| SC 13G | 2024-06-07 |
| 4 | 2024-06-03 |
| SC 13G/A | 2024-06-03 |
| 13F-HR | 2024-05-15 |
| 3 | 2024-03-20 |
| SC 13G/A | 2024-03-20 |
View VIKING GLOBAL INVESTORS LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.